Cargando…
Small molecules targeting Pin1 as potent anticancer drugs
Background: Pin1 is a member of the evolutionarily conserved peptidyl-prolyl isomerase (PPIase) family of proteins. Following phosphorylation, Pin1-catalyzed prolyl-isomerization induces conformational changes, which serve to regulate the function of many phosphorylated proteins that play important...
Autores principales: | Zhang, Jing, Zhou, Wenwen, Chen, Yunyu, Wang, Yanchang, Guo, Zongru, Hu, Wenhui, Li, Yan, Han, Xiaomin, Si, Shuyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083437/ https://www.ncbi.nlm.nih.gov/pubmed/37050909 http://dx.doi.org/10.3389/fphar.2023.1073037 |
Ejemplares similares
-
The expression and significance of efferocytosis and immune checkpoint related molecules in pancancer samples and the correlation of their expression with anticancer drug sensitivity
por: Cheng, Lin, et al.
Publicado: (2022) -
Microbiota and their metabolites potentiate cancer immunotherapy: Therapeutic target or resource for small molecule drug discovery?
por: Du, Peixin, et al.
Publicado: (2022) -
Evaluating anticancer properties of Withaferin A—a potent phytochemical
por: Atteeq, Maushma
Publicado: (2022) -
Model-Based Meta-Analysis in Psoriasis: A Quantitative Comparison of Biologics and Small Targeted Molecules
por: He, Huan, et al.
Publicado: (2021) -
MicroRNA as an Important Target for Anticancer Drug Development
por: Fu, Zhiwen, et al.
Publicado: (2021)